Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Hara

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Breast Cancer (Tokyo, Japan)|January 15, 2003
Estrogen receptor alpha mutation (A-to-G transition at nucleotide 908) is not found in different types of breast lesions from Japanese womenZhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|July 15, 2010
[Comparison of dose distribution on radiographic film and radiochromic film for intensity modulated radiation therapy]Motoharu Sasaki, Masahide Tominaga, Hitoshi Ikushima, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2003
p33(ING1b) stimulates the transcriptional activity of the estrogen receptor alpha via its activation function (AF) 2 domainTatsuya Toyama, Hirotaka Iwase, Hiroko Yamashita, et al.
Cancer Letters|July 16, 2005
NCOR1 mRNA is an independent prognostic factor for breast cancerZhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, et al.
Breast Cancer Research and Treatment|September 21, 2005
Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|June 14, 2011
[Impact of multileaf collimator leaf positioning accuracy on intensity modulated radiation therapy]Motoharu Sasaki, Masahide Tominaga, Hitoshi Ikushima, et al.
Cancer Letters|March 15, 2003
ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junctionYasuo Hara, Zuoyu Zheng, Susan C Evans, et al.
Cancer Research|October 3, 2003
ING1 represses transcription by direct DNA binding and through effects on p53Hiromi Kataoka, Paul Bonnefin, Diego Vieyra, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2006
Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancerToshinari Yamashita, Hiroko Yamashita, Yukashi Itoh, et al.
Neuroscience Letters|September 8, 2009
Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patientsYoshiro Saito, Takao Hamakubo, Yasukazu Yoshida, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Breast Cancer (Tokyo, Japan)|January 15, 2003
Estrogen receptor alpha mutation (A-to-G transition at nucleotide 908) is not found in different types of breast lesions from Japanese womenZhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|July 15, 2010
[Comparison of dose distribution on radiographic film and radiochromic film for intensity modulated radiation therapy]Motoharu Sasaki, Masahide Tominaga, Hitoshi Ikushima, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2003
p33(ING1b) stimulates the transcriptional activity of the estrogen receptor alpha via its activation function (AF) 2 domainTatsuya Toyama, Hirotaka Iwase, Hiroko Yamashita, et al.
Cancer Letters|July 16, 2005
NCOR1 mRNA is an independent prognostic factor for breast cancerZhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, et al.
Breast Cancer Research and Treatment|September 21, 2005
Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|June 14, 2011
[Impact of multileaf collimator leaf positioning accuracy on intensity modulated radiation therapy]Motoharu Sasaki, Masahide Tominaga, Hitoshi Ikushima, et al.
Cancer Letters|March 15, 2003
ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junctionYasuo Hara, Zuoyu Zheng, Susan C Evans, et al.
Cancer Research|October 3, 2003
ING1 represses transcription by direct DNA binding and through effects on p53Hiromi Kataoka, Paul Bonnefin, Diego Vieyra, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2006
Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancerToshinari Yamashita, Hiroko Yamashita, Yukashi Itoh, et al.
Neuroscience Letters|September 8, 2009
Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patientsYoshiro Saito, Takao Hamakubo, Yasukazu Yoshida, et al.
Pageof 3